Site Content

Designed to measure levels of beneficial, commensal and pathogenic bacteria

Calprotectin is a reliable, noninvasive marker for differentiating gastrointestinal inflammation associated with IBD from inflammation that maybe associated with IBS

The GI Effects Microbial Ecology profile tests for the status of intestinal bacteria, helping to identify predominate, opportunistic and pathogenic bacteria using DNA analysis

The GI Effects Comprehensive profile uses technology to provide a detailed picture of the balance of the microbiome, including yeast, parasites and bacteria that live in the large intestine.  GIFX also gives insight into the digestive function, intestinal inflammation and the overall health of the gut.

The Gastrointestinal Microbial Assay Plus (GI MAP) assesses a patient's microbiome from stool sample, with particular attention to microbes that may be disturbing normal microbial balance and contribute to perturbations in the GI flora.

Zonulin has been identified as a key biomarker for intestinal permeability, which has been associated with celiac disease, non-celiac gluten sensitivity (NCGS), and other GI and systemic conditions.

This test helps to detect abnormal levels of specific yeast species in the stool.  This helps to tailor treatment

Small Intestinal Bacterial Overgrowth (SIBO) occurs when bacteria enter the normally sterile small intestine and begin to take up residence.  SIBO is a disorder of excessive bacterial growth in the small intestine.

Zonulin has been identified as a key biomarker for intestinal permeability, which has been associated with celiac disease, non-celiac gluten sensitivity (NCGS), and other GI and systemic conditions.

Using qPCR technology.   Used to provide a comprehensive analysis of the GI ecosystem.

Able to assess inflammation, immune function, digestion, gut barrier health, IBD, SCFA production, SIBO and dysbiosis

More and more research suggests that our Oral Microbiome is key to our health.

This is a saliva test 

Using qPCR technology, which provides accurate analysis of the microbiota abundance, inflammatory markers and pH.

Dysbiosis of the vaginal microbiota has been linked to BV, premature delivery, infertility, miscarriages and increased risk of STIs